These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with KIT/PDGFRA gene "homozygous mutation": a multicenter retrospective cohort study]. Shen YY, Li XQ, Yang LX, Fang Y, Nie MM, He ZR, Hou YY, Cao H, Wang M, Shen KT. Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep 25; 24(9):804-813. PubMed ID: 34530562 [Abstract] [Full Text] [Related]
9. P16 overexpression in BRAF-mutated gastrointestinal stromal tumors. Shi SS, Wang X, Xia QY, Rao Q, Shen Q, Ye SB, Li R, Shi QL, Lu ZF, Ma HH, Zhou XJ. Expert Rev Mol Diagn; 2017 Feb 25; 17(2):195-201. PubMed ID: 28034324 [Abstract] [Full Text] [Related]
11. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y. Am J Surg Pathol; 2011 Sep 25; 35(9):1287-95. PubMed ID: 21836495 [Abstract] [Full Text] [Related]
12. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B, Hornick JL, Corless CL, Fletcher CD. Am J Surg Pathol; 2009 Mar 25; 33(3):437-46. PubMed ID: 19011564 [Abstract] [Full Text] [Related]
14. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation]. Li XQ, Tu L, Wang M, Ma XL, Yang LX, Shen YY, Zhuang C, Zhao WY, Qiu JF, Zhao G, Cao H. Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep 25; 23(9):872-879. PubMed ID: 32927512 [Abstract] [Full Text] [Related]
20. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations. Rizzo FM, Palmirotta R, Marzullo A, Resta N, Cives M, Tucci M, Silvestris F. BMC Cancer; 2016 Feb 11; 16():87. PubMed ID: 26867653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]